1
|
Sardaru MC, Rosca I, Ursu C, Dascalu IA, Ursu EL, Morariu S, Rotaru A. Photothermal Hydrogel Composites Featuring G4-Carbon Nanomaterial Networks for Staphylococcus aureus Inhibition. ACS OMEGA 2024; 9:15833-15844. [PMID: 38617624 PMCID: PMC11007816 DOI: 10.1021/acsomega.3c07724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/05/2023] [Revised: 03/06/2024] [Accepted: 03/20/2024] [Indexed: 04/16/2024]
Abstract
Microbial infections represent a significant health risk, often leading to severe complications and, in some cases, even fatalities. As a result, there is an urgent need to explore innovative drug delivery systems and alternative therapeutic techniques. The photothermal therapy has emerged as a promising antibacterial approach and is the focus of this study. Herein, we report the successful synthesis of two distinct supramolecular composite hydrogels by incorporating graphene oxide (GO) and single-walled carbon nanotubes (SWNTs) into guanosine quadruplex (G4) based hydrogels containing covalently bound β-cyclodextrin (β-CD). The G4 matrix was synthesized through a two-step process, establishing a robust network between G4 and β-CDs, followed by the encapsulation of either GO or SWNTs. Comprehensive characterization of these composite hydrogels were conducted using analytical techniques, including circular dichroism, Raman spectroscopy, rheological investigations, X-ray diffraction, and scanning electron microscopy. A notable discovery from the conducted research is the differential photothermal responses exhibited by the hydrogels when exposed to near-infrared laser irradiation. Specifically, SWNT-based hydrogels demonstrated superior photothermal performance, achieving a remarkable temperature increase of up to 52 °C, in contrast to GO-based hydrogels, which reached a maximum of 34 °C. These composite hydrogels showed good cytotoxicity evaluation results and displayed synergistic antibacterial activity against Staphylococcus aureus, positioning them as promising candidates for antibacterial photothermic platforms, particularly in the context of wound treatment. This study offers a valuable contribution to the development of advanced and combined therapeutic strategies for combating microbial infections and highlights the potential of carbon nanomaterial-enhanced supramolecular hydrogels in photothermal therapy applications.
Collapse
Affiliation(s)
- Monica-Cornelia Sardaru
- The
Research Institute of the University of Bucharest (ICUB), 90 Sos. Panduri, 050663 Bucharest, Romania
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Centre of Advanced Research in Bionanoconjugates and
Biopolymers, Grigore
Ghica Voda Alley 41 A, 700487 Iasi, Romania
| | - Irina Rosca
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Centre of Advanced Research in Bionanoconjugates and
Biopolymers, Grigore
Ghica Voda Alley 41 A, 700487 Iasi, Romania
| | - Cristian Ursu
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Physics of Polymers and Polymeric Materials Laboratory, Grigore Ghica Voda Alley 41 A, 700487 Iasi, Romania
| | - Ioan-Andrei Dascalu
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Centre of Advanced Research in Bionanoconjugates and
Biopolymers, Grigore
Ghica Voda Alley 41 A, 700487 Iasi, Romania
| | - Elena-Laura Ursu
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Centre of Advanced Research in Bionanoconjugates and
Biopolymers, Grigore
Ghica Voda Alley 41 A, 700487 Iasi, Romania
| | - Simona Morariu
- Natural
Polymers, Bioactive and Biocompatible Materials, “Petru Poni” Institute of Macromolecular Chemistry,
Romanian Academy, Grigore
Ghica Voda Alley 41 A, Iasi 700487, Romania
| | - Alexandru Rotaru
- “Petru
Poni” Institute of Macromolecular Chemistry, Romanian Academy, Centre of Advanced Research in Bionanoconjugates and
Biopolymers, Grigore
Ghica Voda Alley 41 A, 700487 Iasi, Romania
| |
Collapse
|
2
|
Zhao C, Pan B, Wang T, Yang H, Vance D, Li X, Zhao H, Hu X, Yang T, Chen Z, Hao L, Liu T, Wang Y. Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment. Pharmaceutics 2023; 15:2729. [PMID: 38140070 PMCID: PMC10747500 DOI: 10.3390/pharmaceutics15122729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 11/28/2023] [Accepted: 12/01/2023] [Indexed: 12/24/2023] Open
Abstract
Cancer is a serious disease with an abnormal proliferation of organ tissues; it is characterized by malignant infiltration and growth that affects human life. Traditional cancer therapies such as resection, radiotherapy and chemotherapy have a low cure rate and often cause irreversible damage to the body. In recent years, since the traditional treatment of cancer is still very far from perfect, researchers have begun to focus on non-invasive near-infrared (NIR)-responsive natural macromolecular hydrogel assembly drugs (NIR-NMHADs). Due to their unique biocompatibility and extremely high drug encapsulation, coupling with the spatiotemporal controllability of NIR, synergistic photothermal therapy (PTT), photothermal therapy (PDT), chemotherapy (CT) and immunotherapy (IT) has created excellent effects and good prospects for cancer treatment. In addition, some emerging bioengineering technologies can also improve the effectiveness of drug delivery systems. This review will discuss the properties of NIR light, the NIR-functional hydrogels commonly used in current research, the cancer therapy corresponding to the materials encapsulated in them and the bioengineering technology that can assist drug delivery systems. The review provides a constructive reference for the optimization of NIR-NMHAD experimental ideas and its application to human body.
Collapse
Affiliation(s)
- Chenyu Zhao
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
- Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China;
- Liaoning Province Key Laboratory of Forensic Bio-Evidence Sciences, Shenyang 110122, China
- Center of Forensic Investigation, China Medical University, Shenyang 110122, China
| | - Boyue Pan
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
- Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China;
- Liaoning Province Key Laboratory of Forensic Bio-Evidence Sciences, Shenyang 110122, China
- Center of Forensic Investigation, China Medical University, Shenyang 110122, China
| | - Tianlin Wang
- Department of Biophysics, School of Intelligent Medicine, China Medical University, Shenyang 110122, China; (T.W.); (H.Y.)
| | - Huazhe Yang
- Department of Biophysics, School of Intelligent Medicine, China Medical University, Shenyang 110122, China; (T.W.); (H.Y.)
| | - David Vance
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
- School of Pharmacy, Queen’s University Belfast, Belfast BT7 1NN, UK
| | - Xiaojia Li
- Teaching Center for Basic Medical Experiment, China Medical University, Shenyang 110122, China; (X.L.); (H.Z.)
| | - Haiyang Zhao
- Teaching Center for Basic Medical Experiment, China Medical University, Shenyang 110122, China; (X.L.); (H.Z.)
| | - Xinru Hu
- The 1st Clinical Department, China Medical University, Shenyang 110122, China;
| | - Tianchang Yang
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
| | - Zihao Chen
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
| | - Liang Hao
- Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China;
- Liaoning Province Key Laboratory of Forensic Bio-Evidence Sciences, Shenyang 110122, China
- Center of Forensic Investigation, China Medical University, Shenyang 110122, China
| | - Ting Liu
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
| | - Yang Wang
- China Medical University—The Queen’s University Belfast Joint College, China Medical University, Shenyang 110122, China; (C.Z.); (B.P.); (D.V.); (T.Y.); (Z.C.)
- Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China;
- Liaoning Province Key Laboratory of Forensic Bio-Evidence Sciences, Shenyang 110122, China
- Center of Forensic Investigation, China Medical University, Shenyang 110122, China
| |
Collapse
|